Filana Therapeutics, Inc. (FLNA) Tops Q1 EPS by 10c

Filana Therapeutics, Inc. (NASDAQ: FLNA) reported Q1 EPS of ($0.21), $0.10 better than the analyst estimate of ($0.31).

For earnings history and earnings-related data on Filana Therapeutics, Inc. (FLNA) click here.

You May Also Be Interested In

• Barrick Mining said to delay IPO of American gold business to 2027
• White House: barrels from Venezuela deal could hit reserves in U.S. In November
• DoJ requests beef price data from major retailers including Amazon and Walmart